Effect of methionine‐deficient and methionine‐supplemented diets on the hepatic one‐carbon and lipid metabolism in mice
SCOPE: A compromised nutritional status in methyl‐group donors may provoke several molecular alterations triggering the development of nonalcoholic fatty liver disease (NAFLD) in humans and experimental animals. In this study, we investigated a role and the underlying molecular mechanisms of methion...
Saved in:
Published in | Molecular nutrition & food research Vol. 58; no. 7; pp. 1502 - 1512 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag GmbH & Co. KGaA
01.07.2014
Blackwell Publishing Ltd Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | SCOPE: A compromised nutritional status in methyl‐group donors may provoke several molecular alterations triggering the development of nonalcoholic fatty liver disease (NAFLD) in humans and experimental animals. In this study, we investigated a role and the underlying molecular mechanisms of methionine metabolic pathway malfunctions in the pathogenesis of NAFLD. METHODS AND RESULTS: We fed female Swiss albino mice a control (methionine‐adequate) diet and two experimental (methionine‐deficient or methionine‐supplemented) diets for 10 weeks, and the levels of one‐carbon metabolites, expression of one‐carbon and lipid metabolism genes in the livers were evaluated. We demonstrate that both experimental diets increased hepatic levels of S‐adenosyl‐l‐homocysteine and homocysteine, altered expression of one‐carbon and lipid metabolism genes, and caused lipid accumulation, especially in mice fed the methionine‐deficient diet. Markers of oxidative and ER stress response were also elevated in the livers of mice fed either diet. CONCLUSION: Our findings indicate that both dietary methionine deficiency and methionine supplementation can induce molecular abnormalities in the liver associated with the development of NAFLD, including deregulation in lipid and one‐carbon metabolic pathways, and induction of oxidative and ER stress. These pathophysiological events may ultimately lead to lipid accumulation in the livers, triggering the development of NAFLD. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/mnfr.201300726 ArticleID:MNFR2202 Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) - No. 2010/01410-0; No. 2012/10872-2 istex:7FD19A0EE91ACCB2AA7D9F288D3BDF9D5AB9DE7E ark:/67375/WNG-1RNTX9XK-7 These authors contributed equally to work. The views expressed in this paper do not necessarily represent those of the U.S. Food and Drug Administration. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1613-4125 1613-4133 |
DOI: | 10.1002/mnfr.201300726 |